Clozapine-induced weight gain associated with the 5HT2C receptor -759C/T polymorphism

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 133 B, Issue 1, 2005, Pages 97-100

  Miller, Del D ^a   Ellingrod, Vicki L ^b   Holman, Timothy L ^a,b   Buckley, Peter F ^c   Arndt, Stephan ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

5HT2C receptor; Body mass index; Clozapine; Weight gain

Indexed keywords

CLOZAPINE; SEROTONIN RECEPTOR;

ADULT; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; HUMAN; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; WEIGHT GAIN;

ADULT; ALLELES; ANTIPSYCHOTIC AGENTS; BODY MASS INDEX; CLOZAPINE; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, SEROTONIN, 5-HT2C; SCHIZOPHRENIA; WEIGHT GAIN;

EID: 12944265464     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30115     Document Type: Article

References (16)

1. Allison DB, Mentore JL, Moonseon H, Chandler LP, Cappelleri JC, Infante MC, Weiden PJ. 1999. Antipsychotic-induced weight gain: A comprehensive research synthesis. Am J Psychiatry 156:1686-1696.
2. Basile VS, Masellis M, De Luca V, Meltzer HY, Kennedy JL. 2002. -759C/T genetic variation of 5HT2c receptor and clozapine-induced weight gain. Lancet 360:1790-1791.
3. Comuzzie AG, Allison DB. 1998. The search for human obesity genes. Science 280(5368):1374-1377.
4. Ellingrod VL, Perry PJ, Ringold JC, Lund BJ. Bever-Stille K, Fleming F, Holman TL, Miller DD. 2004. Weight gain associated with the -759 C/T polymorphism of the 5HT2C receptor and olanzapine. Am J Med Genet (in press).
5. Kroeze WK, Hufeisen SJ, Popadak BA, Renock SM, Steinberg S, Ernsberger P, Jayathilake K, Meltzer HY, Roth BL. 2003. H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology 28(3):519-526.
6. Lappalainen J, Zhang L, Dean M, Oz M, Ozaki N, Yu DH, Virkkunen M, Weight F, Linnoila M, Goldman D. 1995. Identification, expression, and pharmacology of a Cys23-Ser23 substitution in the human 5-HT2C receptor gene (HTR2C). Genomics 27:274-279.
7. Leadbetter R, Shutty M, Pavalonis D, Vieweg V, Higgins P, Downs M. 1992. Clozapine-induced weight gain: Prevalence and clinical relevance. Am J Psychiatry 149(1):68-72.
8. Overall J, Gorham D. 1962. Brief psychiatric rating scale. Psychol Rep 10:799-812.
9. Reynolds GP, Zhang AJ, ZhangXB. 2002. Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism. Lancet 359:2086-2087.
10. Reynolds GP, Zhang ZJ, Zhang XB. 2003. Clozapine-induced weight gain associated with a polymorphism of the promotor region of the 5-HT2C receptor gene. Am J Psychiatry 160:677-679.
11. Shih JC, Zhu Q, Chen K. 1996. Determination of transcription initiation sites and promoter activity of the human 5-HT2A receptor gene. Behav Brain Res 73:59-62.
12. Tecott LH, Sun LM, Akana SF, Strack AM, Lowenstein DH, Dallman MF, Julis D. 1995. Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors. Nature 374:542-546.
13. Tsai SJ, Hong CJ, Yu YW-Y, Lin CH. 2202. -759C/T genetic variation of 5HT2c receptor and clozapine-induced weight gain. Lancet 360:1790.
14. Umbricht DS, Pollack S, Kane JM. 1994. Clozapine and weight gain. J Clin Psychiatry 55(Suppl B):157-160.
15. VanderZwaag C, McGee M, McEvoy JP, Freudenreich O, Wilson WH, Cooper TB. 1996. Response of patients with treatment-refractory schizophrenia to clozapine within three serum level ranges. Am J Psychiatry 153:1579-1584.
16. Yuan X, Yamada K, Ishiyama-Shigemoto S, Koyama W, Nonaka K. 2000. Identification of polymorphic loci in the promoter region of the serotonin 5-HT2C receptor gene and their association with obesity and Type II diabetes. Diabetologia 43:373-376.